Methods, systems and equipment useful for monitoring in vivo activities of CCI-779 or other drugs. Numerous drug activity genes can be identified by the present invention. The expression profiles of these genes in peripheral blood mononuclear cells are modulatable by CCI-779 or other drugs. Therefore, these genes can be used as surrogate markers for detecting or monitoring drug activities in vivo.

 
Web www.patentalert.com

< System and method for detection of brain edema using spectrophotometry

> Physiological stress detector device and system

> Mesh network stroke monitoring appliance

~ 00574